Bacteria have garnered significant attention in tumor immunotherapy recently years, owing
to their immune‐activating properties, ease of genetic manipulation, and colonization …

With the in-depth understanding of the anti-cancer immunity, immunotherapy has become a
promising cancer treatment after surgery, radiotherapy, and chemotherapy. As natural …

Bacteria have been widely exploited as therapeutic agents for immunotherapy due to their
native immunogenicity, living characteristic, and genetic manipulability. However …

In recent years, cancer therapy strategies utilizing live tumor-targeting bacteria have
presented unique advantages. Engineered bacteria have the particular ability to distinguish …

As the limitations of cancer immunotherapy become increasingly apparent, there is
considerable anticipation regarding the utilization of biological tools to enhance treatment …

The past decade has witnessed a great leap forward in bacteria-based living agents,
including imageable probes, diagnostic reagents, and therapeutics, by virtue of their unique …

The use of living bacteria either as therapeutic agents or drug carriers has shown great
potential in treating a multitude of intractable diseases. However, cells are often fragile to …

Targeted therapy and immunotherapy have brought hopes for precision cancer treatment.
However, complex physiological barriers and tumor immunosuppression result in poor …

Simple Summary Cancer refers to a disease involving abnormal cells that proliferate
uncontrollably and can invade normal body tissue. It was estimated that at least 9 million …

The engineering of living cells and microbes is ushering in a new era of cancer therapy. Due
to recent microbiome studies indicating the prevalence of bacteria within the human body …